Artificial Intelligence
AI in Precision Oncology and How It Can Redefine Cancer Care
Peter Casasanto, Chief Biopharma Officer of Sophia Genetics, joins Jill Malandrino on Nasdaq TradeTalks to discuss AI in precision oncology and how it can redefine cancer care.